Table 2 Perioperative and oncologic outcomes
From: Predictors of mortality within the first year post-hepatectomy for hepatocellular carcinoma
Number (n = 163) | |
|---|---|
Tumor size (mm), median (range) | 40 (1 – 200) |
Macrovascular invasion | 18 (11%) |
Microvascular invasion | 47 (28.8%) |
Pringles maneuver used | 27 (16.6%) |
Competing interests | Competing interests |
Major resection | 74 (45.4%) |
Right hemihepatectomy | 37 (50%) |
Left hemihepatectomy | 21 (28.4%) |
Right trisectionectomy | 12 (16.2%) |
Left trisectionectomy | 1 (1.4%) |
Central hepatectomy | 3 (4%) |
Minor resection | 89 (54.6%) |
Laparoscopic resection | 101 (62%) |
Multifocal (≥ 2) tumors | 43 (26.4%) |
Giant (≥ 10 cm) tumor | 32 (19.6%) |
Blood transfusion | 30 (18.4%) |
Pneumonia | 14 (8.6%) |
Acute renal failure | 7 (4.3%) |
Urinary tract infection | 6 (3.7%) |
Pulmonary embolism | 1 (0.6%) |
Intra-abdominal abscess | 4 (2.5%) |
Bile leak | 3 (1.8%) |
Superficial surgical site infection | 7 (4.3%) |
Post-hepatectomy liver failure 1 (50–50 criteria) | 6 (3.7%) |
Post-hepatectomy liver failure 2 (peak serum bilirubin criteria) | 7 (4.3%) |
Post-hepatectomy liver failure 3 (ISGLS criteria) | 25 (15.3%) |
30-Day mortality | 6 (3.7%) |
90-Day mortality | 8 (4.9%) |
One-year mortality | 15 (9.2%) |